Bryan Johnson said on Sunday that Kate Tolo’s period would “start any minute now,” a milestone the longevity biohacker has been tracking for 34 straight days as part of what he calls “the most measured menstrual cycle in history.” The post on X landed Aug. 30 with a full data dump and a photo of Tolo, 30, his partner and the co-founder of his longevity companies.
Johnson listed the totals: 408 minutes of brain activity, more than 10,000 blood glucose readings, 48,960 core body temperature measurements and 136 full-body photos. The couple have logged about 14 million data points across the cycle, run by a 12-person medical team and more than 50 monitoring devices, according to a Wall Street Journal interview with Tolo that Independent and other outlets picked up in late July.
The project lands at a moment when women’s reproductive health is widely flagged as a research backwater. Average diagnosis time for endometriosis in the United States runs about 6.6 years, and Tolo says she was diagnosed with endometriosis, polycystic ovary syndrome and adenomyosis in 42 days through non-invasive imaging, blood work and AI-assisted MRI. Endometriosis is tissue similar to the uterine lining growing outside the uterus. PCOS disrupts ovulation. Adenomyosis happens when that lining pushes into the uterine muscle. All three can cause pain, irregular bleeding and fertility problems.
Johnson has also been storing Tolo’s period blood in a cup in a minus-80°C lab freezer at his home, a detail first reported in late July and explored further in a Guardian column on the menstrual-blood experiment and a New York Post explainer on the freezer protocol. The reaction to the Aug. 30 milestone post split fast. The thread pulled more than 25,000 likes and several hundred replies in hours, with supporters praising the transparency and critics questioning the optics and the spend.
Tolo’s daily schedule runs more than 100 individual tasks, from ingestible core-temperature pills and brain-activity monitors to vaginal-microbiome swabs, cervical-mucus checks, DNA-methylation panels, oral and stool microbiome samples, urine hormone-metabolite panels, resting-metabolic-rate readings and an experimental “techno-tampon” device that monitors menstrual blood flow. The July report on the protocol detailed 88 of those tasks. Johnson and Tolo say the entire data set will be released free to outside researchers once the project wraps.
Tolo framed the work in humanitarian terms in her July interview with the Journal. “I’m really doing it because I think that this is our path toward women being understood in the world and being seen,” she said. The project costs about $2.6 million a year, funded through Immortals, the couple’s supplements-and-concierge-medicine company, rather than from a research grant.
Tolo is an Australian-Bosnian-American entrepreneur who worked in fashion before co-founding Blueprint, Don’t Die and Immortals with Johnson. She is the first woman and the second person, after Johnson, to trial Blueprint. The pair met through the Los Angeles longevity scene in late 2020 and began dating shortly after. Johnson introduced Tolo publicly in a December 2025 X thread that compared their partnership to John Adams and Abigail Adams and called Tolo “the puzzle piece” that helped him move past his own guarded past. People magazine and Mashable covered the thread when it went viral.
Johnson has also said he has never shared a bed with Tolo, citing research on separate sleep for better rest. Tolo later revealed Johnson agreed to share a bed with her for three nights as a controlled experiment after she hit 100 days of her own routine. Outside the couple’s circle, OB-GYNs who spoke to the Journal and The Guardian stopped short of endorsing the protocol but agreed the underlying point is sound: women’s cycles are chronically under-measured, and the field’s biggest data gaps sit in conditions like the ones Tolo was just diagnosed with.
The 34-day update also lands in the middle of a wider backlash against Johnson himself. He is fighting Bryan Johnson’s earlier clash with The New York Times over the paper’s coverage of his routine, and he publicly shared his own recent autoimmune diagnosis earlier this year. Critics inside the anti-aging and longevity space argue the menstrual project doubles as a reputational counterweight, a way to redirect attention from Johnson’s own health setbacks toward a cause framed as altruistic.
Money is not the obstacle. Johnson founded Braintree in 2007 and sold the payments platform, by then bundled with Venmo, to PayPal in September 2013 for $800 million, a figure confirmed at the time by Forbes’ account of the Braintree sale. He also co-founded Kernel, the brain-monitoring hardware company, and has spent years publicly tracking his own aging markers in an attempt to slow or reverse them.
The 34-day cycle is, by Johnson’s own framing, the opening round. Tolo’s period could begin at any moment, which would close the window and open the next one, with a fresh batch of measurements ready for analysis. Whether the resulting data set ends up reshaping care for the 10 percent of reproductive-age women affected by endometriosis, or ends up another flashpoint in the biohacking culture war, depends on what the next 34 days, and the ones after, actually measure.

